Evidence map›Paper›PMID 26731012›Full record

ArticlePloS one2016

National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia.

Sara G Murray, Gabriela Schmajuk, Laura Trupin, Lianne Gensler, Patricia P Katz, Edward H Yelin, Stuart A Gansky, Jinoos Yazdany

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. [Systemic lupus erythematosus : Unusual cutaneous manifestations].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2016
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sara G MurrayDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Gabriela SchmajukDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Laura TrupinDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Lianne GenslerDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Patricia P KatzDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Edward H YelinDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Stuart A GanskyDivision of Oral Epidemiology and Dental Public Health, Department of Preventive and Restorative Dental Sciences, University of California San Francisco, San Francisco, California, United States of America.
Jinoos YazdanyDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
University of California, San Francisco · USLee University · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
The Interplay of Sociodemographic and Genetic Factors in SLE Health DisparitiesP60AR053308 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YELIN, EDWARD H · 2006 to 2016
$11.8M
ASPIRE: Advancing Safety Process Innovation in RheumatologyR01HS024412 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAZDANY, JINOOS · 2015 to 2017
$1.4M
A rational approach to liver toxicity monitoring in methotrexate usersK23AR063770 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHMAJUK, GABRIELA · 2013 to 2017
$670k
Evaluating Health Care Quality in Systemic Lupus ErythematosusK23AR060259 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAZDANY, JINOOS · 2011 to 2015
$638k
AHRQ HHS R01 HS024412NCRR NIH HHS 3UL1RR024131-04S1NCRR NIH HHS UL1 RR024131NIAMS NIH HHS K23 AR060259NIAMS NIH HHS K23 AR063770NIAMS NIH HHS P60 AR053308
6 · The paper itself

Abstract

objectiveInfection is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). Therapeutic practices have evolved over the past 15 years, but effects on infectious complications of SLE are unknown. We evaluated trends in hospitalizations for severe and opportunistic infections in a population-based SLE study.

methodsData derive from the 2000 to 2011 United States National Inpatient Sample, including individuals who met a validated administrative definition of SLE. Primary outcomes were diagnoses of bacteremia, pneumonia, opportunistic fungal infection, herpes zoster, cytomegalovirus, or pneumocystis pneumonia (PCP). We used Poisson regression to determine whether infection rates were changing in SLE hospitalizations and used predictive marginals to generate annual adjusted rates of specific infections.

resultsWe identified 361,337 SLE hospitalizations from 2000 to 2011 meeting study inclusion criteria. Compared to non-SLE hospitalizations, SLE patients were younger (51 vs. 62 years), predominantly female (89% vs. 54%), and more likely to be racial/ethnic minorities. SLE diagnosis was significantly associated with all measured severe and opportunistic infections. From 2000 to 2011, adjusted SLE hospitalization rates for herpes zoster increased more than non-SLE rates: 54 to 79 per 10,000 SLE hospitalizations compared with 24 to 29 per 10,000 non-SLE hospitalizations. Conversely, SLE hospitalizations for PCP disproportionately decreased: 5.1 to 2.5 per 10,000 SLE hospitalizations compared with 0.9 to 1.3 per 10,000 non-SLE hospitalizations.

conclusionsAmong patients with SLE, herpes zoster hospitalizations are rising while PCP hospitalizations are declining. These trends likely reflect evolving SLE treatment strategies. Further research is needed to identify patients at greatest risk for infectious complications.

Indexed as

AdolescentAdultAgedBacteremiaComorbidityCytomegalovirus InfectionsDisease SusceptibilityFemaleHerpes ZosterHospitalizationHumansImmunocompromised HostLupus Erythematosus, SystemicMaleMiddle AgedMorbidity

Identifiers

PMID26731012
PMCPMC4701172
OpenAlexW2310274426

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.